 
| Subject: | |
| From: | |
| Reply To: | |
| Date: | Fri, 3 Dec 2004 09:27:27 -0800 |
| Content-Type: | text/plain |
| Parts/Attachments: |
|
|
Found their previous article.
Judy Ritchie
http://nutraingredients.com/news/news-NG.asp?n=53306-puleva-biotech-gets
Puleva Biotech gets funding boost for new probiotics
06/07/2004 - Puleva Biotech, the biotech arm of Spanish food group Ebro
Puleva, has been awarded funding worth ˆ428,290 from a regional development
fund to help it start up a new probiotics line.
The R&D firm recently reported that it was ready to produce selected
strains, isolated from human breastmilk, for the commercial market.
“These are the same bacteria being transferred to babies to shore up their
immune system for the years ahead. These are therefore the best kind of
bacteria you can get,” Julio Boza Puerta, managing vicedirector at Puleva
Biotech, told www.NutraIngredients.com
at Vitafoods earlier this year.
***********************************************
To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html
|
|
|
